SummaryRMgm-4876
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene disruption |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 33287434 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 507cl1 (RMgm-7) |
Other information parent line | P.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Guttery DS, Tewari R |
Name Group/Department | School of Life Sciences |
Name Institute | University of Nottingham |
City | Nottingham |
Country | UK |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-4876 |
Principal name | Δmre11 |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Not different from wild type |
Oocyst | There were significantly fewer oocysts in Δmre11 lines, and the vast majority of these oocysts were significantly smaller than WT-GFP oocysts. In none of the Δmre11 oocysts was there any evidence of sporozoite development, and those of similar size to WT-GFP oocysts had patterns of fragmented GFP expression and reduced Hoechst DNA-staining. Investigation of the sex-cell lineage of this defect revealed that it could be rescued by crossing Δmre11 parasites with Δmap2 (male-defective) cells, suggesting that the function of MRE11 is inherited through the female. The Δmre11 oocysts had a fully formed wall but the cytoplasm exhibited evidence of degeneration, with vacuolization and organelle breakdown, while the nuclei showed marked swelling of the nuclear membranes |
Sporozoite | no sporozoite formation |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Phenotype
Mre11 mRNA is present in cells throughout the P. berghei life-cycle (except merozoites), based on single cell RNA-seq data, with the highest abundance in ookinetes/oocysts. Analyses of a mutant expressing a C-terminal GFP-tagged version of MRE11 (RMgm-4877) showed the following: Other mutants |
top of page | |||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_0205600 | ||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0107800 | ||||||||||||||||||||||||
Gene product | double-strand break repair protein MRE11 | ||||||||||||||||||||||||
Gene product: Alternative name | MRE11 | ||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||
Type of plasmid/construct used | (Linear) plasmid double cross-over | ||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||
Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
Additional remarks partial/complete disruption | |||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||
Additional remarks genetic modification | The Δmre11 gene-knockout targeting vector was constructed using the pBS-DHFR plasmid, which contains polylinker sites flanking a Toxoplasma gondii dhfr/ts expression cassette, as described previously (53). A 611 bp fragment at the 5′ end of the mre11 sequence was generated from genomic DNA using PCR primers P0141 (5’-CCCCGGGCCCTTGTGCATACACATCAACAGATAA-3’) and P0142 (5’-GGGGAAGCTTATCCAAATCTGATAAGTAATTATCCA-3’) and inserted into pBS-DHFR using ApaI and HindIII restriction sites upstream of the dhfr/ts cassette. A 575 bp fragment generated with primers P0143 (5’-CCCCGAATTCGAATGAATTGAAGGATATCCCAG-3’) and P0144 (5’-GGGGTCTAGACTGTATTGGAGATGAATATTATGGA-3’) from the 3′ region of mre11 was then inserted downstream of the dhfr/ts cassette using EcoRI and XbaI restriction sites. The linear targeting sequence was released using ApaI/XbaI digestion of the plasmid. | ||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||
Primer information: Primers used for amplification of the target sequences
![]() Primer information: Primers used for amplification of the target sequences
![]()
| |||||||||||||||||||||||||
top of page |